Targeted therapies: Smart tumor, smarter treatment

Nature Reviews Clinical Oncology

Volumn 9, Issue 3, 2012, Pages 127-

  Villanueva, M Teresa ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE PHOSPHATASE; SHORT HAIRPIN RNA; TUMOR MARKER; VEMURAFENIB;

CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RESEARCH; CANCER RESISTANCE; CHEMOSENSITIVITY; COLORECTAL CANCER; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEEDBACK SYSTEM; GENE IDENTIFICATION; GENE SILENCING; GENETIC SCREENING; HUMAN; MELANOMA; MOLECULARLY TARGETED THERAPY; MUTATION RATE; NOTE; PRIORITY JOURNAL; RNA INTERFERENCE; TREATMENT DURATION; TREATMENT PLANNING;

EID: 84857920142     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2012.4     Document Type: Note

References (1)

1. ORIGINAL ARTICLE Prahallad A. et al. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature doi:10.1038/nature10868